Virginia Retirement Systems ET AL Grows Holdings in West Pharmaceutical Services Inc. (WST)

Share on StockTwits

Virginia Retirement Systems ET AL raised its stake in West Pharmaceutical Services Inc. (NYSE:WST) by 6.7% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,700 shares of the medical instruments supplier’s stock after buying an additional 800 shares during the period. Virginia Retirement Systems ET AL’s holdings in West Pharmaceutical Services were worth $1,400,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in WST. Ellis Investment Partners LLC acquired a new stake in shares of West Pharmaceutical Services in the first quarter worth $155,000. Oppenheimer Asset Management Inc. grew its position in West Pharmaceutical Services by 6.0% during the first quarter. Oppenheimer Asset Management Inc. now owns 55,357 shares of the medical instruments supplier’s stock valued at $6,101,000 after buying an additional 3,147 shares during the period. Pier Capital LLC grew its position in West Pharmaceutical Services by 185.9% during the first quarter. Pier Capital LLC now owns 84,506 shares of the medical instruments supplier’s stock valued at $9,313,000 after buying an additional 54,946 shares during the period. Mercer Global Advisors Inc. ADV acquired a new stake in West Pharmaceutical Services during the first quarter valued at $702,000. Finally, Brinker Capital Inc. grew its position in West Pharmaceutical Services by 6.2% during the first quarter. Brinker Capital Inc. now owns 22,652 shares of the medical instruments supplier’s stock valued at $2,496,000 after buying an additional 1,331 shares during the period. 94.40% of the stock is owned by institutional investors.

WST stock opened at $121.84 on Friday. The firm has a market cap of $9.13 billion, a P/E ratio of 43.36, a PEG ratio of 3.95 and a beta of 1.29. The company has a current ratio of 3.15, a quick ratio of 2.40 and a debt-to-equity ratio of 0.14. West Pharmaceutical Services Inc. has a one year low of $84.91 and a one year high of $125.09.

West Pharmaceutical Services (NYSE:WST) last released its quarterly earnings results on Thursday, April 25th. The medical instruments supplier reported $0.74 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.66 by $0.08. The company had revenue of $443.50 million for the quarter, compared to analyst estimates of $431.00 million. West Pharmaceutical Services had a net margin of 12.53% and a return on equity of 16.46%. The firm’s revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the business earned $0.62 earnings per share. Research analysts predict that West Pharmaceutical Services Inc. will post 2.86 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, May 1st. Investors of record on Wednesday, April 17th were given a dividend of $0.15 per share. The ex-dividend date of this dividend was Tuesday, April 16th. This represents a $0.60 annualized dividend and a yield of 0.49%. West Pharmaceutical Services’s dividend payout ratio is presently 21.35%.

Several analysts recently commented on the stock. Zacks Investment Research lowered shares of West Pharmaceutical Services from a “hold” rating to a “sell” rating in a research report on Friday, April 19th. Jefferies Financial Group lowered shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating and set a $122.00 price target on the stock. in a research report on Wednesday. Finally, William Blair assumed coverage on shares of West Pharmaceutical Services in a research report on Tuesday, April 23rd. They set an “outperform” rating and a $112.16 price target on the stock.

In other West Pharmaceutical Services news, VP Daniel Malone sold 4,458 shares of the stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $123.03, for a total transaction of $548,467.74. Following the transaction, the vice president now directly owns 33,478 shares of the company’s stock, valued at $4,118,798.34. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 1.70% of the company’s stock.

WARNING: This story was published by Week Herald and is owned by of Week Herald. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://weekherald.com/2019/05/03/virginia-retirement-systems-et-al-grows-holdings-in-west-pharmaceutical-services-inc-wst.html.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.

Read More: Trading Stocks – What are percentage gainers?

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.